Denison Announces Filing of Annual Report on Form 40-F

Stock Information for Enzon Pharmaceuticals Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Enzon Pharmaceuticals Inc

Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan
Denison Announces Option of Non-Core Exploration Projects to Foremost for up to $30 Million in Combined Consideration
Grounded Lithium Announces Robust $4.5 Million Budget Funded by Denison Mines for the Kindersley Lithium Project
Denison CEO Highlights Phoenix Post-Feasibility Study Progress and Company Reports Financial and Operational Results for Q2'2024
Denison Announces Signing of Wheeler River Benefit Agreements with Kineepik Métis Local #9 and the Village of Pinehouse Lake
Denison Announces Completion of Inaugural ISR Field Test Program at Midwest
Denison Announces Results of Shareholder Meeting & Appointment of Jennifer Traub as Board Chair
Denison Reports Financial and Operational Results for Q1 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.